SALT LAKE CITY--(BUSINESS WIRE)--Leavitt Equity Partners (“LEP”), a value-add healthcare focused private equity firm, today announced the closing of its third fund, Leavitt Equity Partners III (“LEP III”). LEP III raised over $180 million, surpassing the investment firm’s initial target of $150 million.
“We are delighted with the outcome of this fundraise and the strong support from both existing and new investors,” said Taylor Leavitt, LEP’s Managing Partner and CEO. LEP III’s Limited Partner base consists primarily of strategic healthcare partners, in addition to insurance companies, foundations, and family offices.
As with predecessor funds, LEP III seeks to invest in lower middle market healthcare companies with a focus on services, care models, and technologies that bring value to healthcare in the form of lower costs, better quality, and better access. “We believe our ability to bring deep healthcare policy and strategic expertise enables significant growth potential for our portfolio companies as we look to support a more value-driven healthcare future,” said Andrew Clark, LEP’s Managing Partner.
Dorsey & Whitney served as legal advisors to Leavitt Equity Partners in the formation of LEP III.
About Leavitt Equity Partners
Leavitt Equity Partners is a value-add, healthcare focused private equity firm. Founded in 2014 by Michael Leavitt, former United States Secretary of the Department of Health and Human Services, LEP leverages the healthcare intelligence and broad network of its Principals to help portfolio companies thrive in a complex and ever-changing healthcare system.
LEP manages over $400 million in capital, raised primarily from strategic healthcare partners including healthcare provider systems, national and regional health insurers, healthcare service providers, healthcare IT companies, pharmaceutical companies, and healthcare executives and entrepreneurs. For more information, please visit www.leavittequity.com.
